PPIA and gastric adenocarcinoma: In contrast, although the expression level of CypA as increased in 63% of gastric adenocarcinoma samples compared to matched samples of normal mucosa, the recurrence and metastasis rate was lower in patients with positive CypA immunostaining after 3 years of follow-up [32].